CCL22 and breast carcinoma: In conclusion, ABCA3, CCL22, FOXJ1, MAP2K6, and IL1RN may serve as good prognostic factors, while KCNIP3 and MRPL13 may be poor prognostic biomarkers to predict the recurrence and prognosis of breast cancer.